[Polysaccharides from Scurrula Parasitica L. Inhibit Sarcoma S180 Growth in Mice]
Overview
Affiliations
To study the anti-tumor activity of Scurrula parasitica polysaccharides (SP). Water extraction and ethanol precipitation were used to isolate SP from S. parasitica leaf. S180, K562 and HL-60 cell lines proliferation inhibition by SP were detected by MTT assay. The expressions of Ki-67, Cyclin D1, Bax and Bcl-2 protein in the sarcoma S180 tissues were detected by immunohistochemistry technique to approach the anti-tumor mechanism of SP+ SP could not inhibit cancer cell proliferation. SP ip could inhibit the growth of sarcoma S180 in mice, 100 mg x kg(-1) x d(-1). SP ip was the optimal dose on inhibiting S180 growth, with the tumor inhibition rate of 54%. The expression of Ki-67, Cyclin D1, Bax and Bcl-2 protein in the sarcoma S180 tissues were detected by immunohistochemistry technique to approach the anti-tumor mechanism of SP. The result showed that SP could down-regulate the expression of Ki-67, CyclinD1 and Bcl-2 protein, and up-regulate the expression of Bax protein. It indicted that inhibiting cancer cell proliferation and promoting cancer cell apoptosis in vivo maybe one of the anti-cancer mechanisms of SP.
Satia Nugraha A, Triatmoko B, Wangchuk P, Keller P Biomolecules. 2020; 10(2).
PMID: 31991657 PMC: 7072150. DOI: 10.3390/biom10020181.
Khan T, Ali M, Khan A, Nisar P, Jan S, Afridi S Biomolecules. 2020; 10(1).
PMID: 31892257 PMC: 7022400. DOI: 10.3390/biom10010047.
A Hidden Treasure: The Borneo Mistletoes.
Lim Y, Rajabalaya R, David S Pharmacogn Rev. 2017; 11(22):153-157.
PMID: 28989251 PMC: 5628522. DOI: 10.4103/phrev.phrev_16_17.
Emerging roles of mistletoes in malignancy management.
Patel S, Panda S 3 Biotech. 2017; 4(1):13-20.
PMID: 28324460 PMC: 3909578. DOI: 10.1007/s13205-013-0124-6.
Huqi San-Evoked Rat Colonic Anion Secretion through Increasing CFTR Expression.
Xue X, Shi Z, Wang W, Yu X, Feng P, Zhang M Evid Based Complement Alternat Med. 2015; 2015:301640.
PMID: 26290673 PMC: 4531196. DOI: 10.1155/2015/301640.